These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3373589)

  • 21. [Adjuvant chemotherapy after cystectomy of bladder tumor].
    Taki Y; Hayashi T; Hiura M; Ryoji O; Takenawa J; Kiriyama T
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3195-203. PubMed ID: 2506838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion.
    Scher HI; Yagoda A; Herr HW; Sternberg CN; Bosl G; Morse MJ; Sogani PC; Watson RC; Dershaw DD; Reuter V
    J Urol; 1988 Mar; 139(3):470-4. PubMed ID: 3343728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
    Koch MO; Coussens D
    Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
    [No Abstract]   [Full Text] [Related]  

  • 24. Current status of adjuvant chemotherapy after radical cystectomy for deeply invasive bladder cancer.
    Skinner DG; Daniels JR; Lieskovsky G
    Urology; 1984 Jul; 24(1):46-52. PubMed ID: 6539997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
    Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS
    Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].
    Fujimoto K; Chihara Y; Kondo H; Hirao Y
    Hinyokika Kiyo; 2006 Jun; 52(6):433-8. PubMed ID: 16848356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
    Hata M; Miyanaga N; Tokuuye K; Saida Y; Ohara K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Hattori K; Shimazui T; Akaza H; Akine Y
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1371-9. PubMed ID: 16580495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [[Neoadjuvant chemotherapy (cisplatin, doxorubicin, cyclophosphamide) in the treatment of invasive urothelial tumors of the bladder. Preliminary results of a prospective study concerning 22 patients].
    Trifard F; Chrétien Y; Vallantin X; Collet C; Lachand AT; Dufour B
    Ann Urol (Paris); 1988; 22(3):216-9. PubMed ID: 3401004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of chemotherapy in advanced urothelial carcinoma: with special reference to combination chemotherapy with adriamycin, cyclophosphamide and cisplatin (ACE chemotherapy)].
    Tobisu K; Matsumoto K; Takai K; Kakizoe T
    Nihon Hinyokika Gakkai Zasshi; 1987 Feb; 78(2):327-34. PubMed ID: 3613336
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial.
    Skinner DG; Daniels JR; Russell CA; Lieskovsky G; Boyd SD; Nichols P; Kern W; Sakamoto J; Krailo M; Groshen S
    J Urol; 1991 Mar; 145(3):459-64; discussion 464-7. PubMed ID: 1997689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant chemotherapy for non-organ confined bladder transitional cell carcinoma.
    Abi-Aad AS
    Acta Urol Belg; 1996 May; 64(2):35-7. PubMed ID: 8701808
    [No Abstract]   [Full Text] [Related]  

  • 32. High-dose intensity, circadian-timed doxorubicin and cisplatin adjuvant chemotherapy for bladder cancer.
    Hrushesky WJ; Roemeling RV; Wood PA; Langevin TR; Lange P; Fraley E
    Cancer Treat Rep; 1987 Oct; 71(10):915-9. PubMed ID: 3652055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant systemic chemotherapy after complete transurethral resection of superficially invasive bladder carcinoma (T1 G3-4 and T2 G2-4).
    Rübben H; Weissbach L; Knebel L; Deutz FJ; Giani G; Graf-Dobberstein C; Gebhard R
    Urol Int; 1990; 45(2):78-83. PubMed ID: 2184564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
    Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA
    J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant chemotherapy for invasive bladder cancer.
    Uekado Y; Shinka T; Hirano A; Ohkawa T
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S24-8. PubMed ID: 3117397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
    Sahwi A; Robert M; Delbos O; Legouffe E; Guiter J; Navratil H
    Prog Urol; 1998 Dec; 8(6):1007-11. PubMed ID: 9894259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Aggressive preoperative chemotherapy in infiltrating bladder carcinoma with a combination of cisplatin, cyclophosphamide and adriamycin. Preliminary report].
    Martínez-Piñeiro JA; de la Peña JJ; Hidalgo L; Cisneros J; Jiménez de León J; Machuca J
    Arch Esp Urol; 1986; 39(1):33-46. PubMed ID: 3707210
    [No Abstract]   [Full Text] [Related]  

  • 38. Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study.
    Stöckle M; Meyenburg W; Wellek S; Voges G; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
    J Urol; 1992 Aug; 148(2 Pt 1):302-6; discussion 306-7. PubMed ID: 1635123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin-II combined intra-arterial chemotherapy for locally advanced bladder cancer: a case series study at a single institution.
    Shimabukuro T; Nakamura K; Uchiyama K; Tei Y; Aoki A; Naito K
    Hinyokika Kiyo; 2006 Feb; 52(2):99-105. PubMed ID: 16541762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preliminary results of prophylactic adjuvant chemotherapy with CISCA in bladder tumors].
    Bittard H
    J Urol (Paris); 1988; 94(7):345-7. PubMed ID: 2464650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.